Researchers have utilized scRNA-seq not only to identify tumor heterogeneity in resistant cell line models and clinical specimens with acquired resistance to EGFR-TKIs but also to characterize individual cell clusters and investigate the distinct resistance mechanisms exhibited by different cell populations [31]. This evidence concerns the gene EGFR and neoplasm.